Back to results
US 7,008,650 B2Granted
Compositions for the treatment of acquired immunodeficiency disease
OwnerPaul Y. S. Laminventor
Life of this patent
Estimating the term…
Abstract
This invention relates to compositions for the treatment of acquired immunodeficiency diseases, especially human immunodeficiency virus (HIV), and its simian and feline counterparts (simian immunodeficiency virus (SIV), and feline immunodeficiency virus (FIV)), and to methods for their use.
Claims9
An antiviral composition comprising effective amounts of extracts of the five herbs:
- Radix Gentianae Longdancao (Gentianae longdancao), Fructus Xanthii Sibirici (Xanthii sibirici), Radix Bupleuri (Bupleurum chinense), Radix Astragali (Astralagus membranaceus), and Chrysanthemum Morifolium (Chrysanthemum morifolium), said composition having a therapeutic index of between at least 80 and 400.
An antiviral pharmaceutical composition comprising effective amounts of extracts of the five herbs:
- Radix Gentianae Longdancao (Gentianae longdancao), Fructus Xanthii Sibirici (Xanthii sibirici), Radix Bupleuri (Bupleurum chinense), Radix Astragali (Astralagus membranaceus), and Chrysanthemum Morifolium (Chrysanthemum morifolium), said composition having a therapeutic index of between at least 80 and 400;
- and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.